Leachables from Dry Powder Inhalers (DPI) - MORE>
Leachables may impact drug efficacy and potency - MORE>
Pharmaceutical Testing – USP <660> containers-glass
Testing glass containers for their hydrolytic resistance to protect your medicinal products
All medicinal products need to be protected and packaged in containers that conform to prescribed standards in order to ensure the safety and effectiveness of medicines.
Testing glass containers for their chemical stability is a critical step in assessing the suitability of a container for a certain drug product and its biological safety. USP compliant testing ensures containers meet the compendial requirements and safeguard the drug’s integrity.
This article will help you understand:
- the glass types
- the regulation and its updates
- the testing: Glass Grains test and Surface Glass test.
Validating ICP-MS for the Analysis of Elemental Impurities According to Draft USP General Chapters <232> & <233>
The presence of impurities in pharmaceutical samples is a concern, not only because of potential toxicity, but also for the potential impact on drug stability, shelf-life, or unwanted side-effects.
This article will help you understand the development of new USP <232> and <233> methodology for the preparation and analysis of
Bridge Bearing Testing
An overview of the Ontario Provincial Standard Specification – OPSS 1202
Bridge bearings are key structural elements in bridges, able to accommodate movements and reduce the stresses involved.
Testing bridge bearings for their physical characteristics is fundamental to ensure quality, performance and structural integrity of bridges.
This guide has been developed with well over two decades of experience and expertise testing bridge bearings in our Ontario polymer testing group.
Learn more about:
- Testing Elastomers
- Testing Performance
- Testing Tolerances
Contact UsWhatever your query, we'll pass it on to our experts and respond within a very short space of time.More details
Dubai Investments Park 1,
The Green Community,
P.O. Box: 34924,
Contact: Jason Dodds - Managing Director
Tel: +971 4 885 1001
Fax: +971 4 885 4004